Rainbow Childrens Medicare Ltd.
-
NSE: RAINBOW
-
BSE: 543524
-
Q
-
V
-
T
Quality Score
High Financial StrengthValuation Score
Expensive ValuationTechnical Score
Technically Moderately BullishBroker average target upside %
-3.50 %
Negative Broker average target upside %
TTM PE Ratio
44.90
Above industry Median
Price to Book Ratio
8.90
High in industry
Operating Revenues Qtr Cr
317.00 Cr
Above industry Median
Net Profit Qtr Cr
53.60 Cr
Above industry Median
RSI
59.30
RSI is mid-range
MFI
75.40
MFI Overbought
MACD
43.60
MACD above Signal and Center
MACD Signal Line
43.00
MACD above Signal and Center
30Day SMA Rs
866.70 Rs
Price above SMA 866.70
50Day SMA Rs
818.60 Rs
Price above SMA 818.63
100Day SMA Rs
779.70 Rs
Price above SMA 779.73
200Day SMA Rs
737.90 Rs
Price above SMA 737.87
Promoter holding %
49.83
No change in Promoter holding
FII holding current Qtr %
19.82
FII holdings fell by 1.00%
MF holding current Qtr %
10.14
MF holdings rise by 0.91%
Institutions holding %
35.20
Institutions holding increased by 0.4800%.
Broker Average Rating
3.00
Broker Average Rating
Broker Covering stock
1.00
1 Broker Covering stock
Broker 1Year total
2.00
2 Broker 1Year total
Broker 6M Reco downgrade
1.00
1 Broker 6M Reco downgrade
Broker 6M Reco upgrade
0.00
0 Broker 6M Reco upgrade
Broker 6M Target downgrade
0.00
0 Broker 6M Target downgrade
Broker 6M Target upgrade
1.00
1 Broker 6M Target upgrade
Momentum score
68.82
Technically Moderately Bullish
Valuation score
19.33
Expensive Valuation
Quality score
87.53
High Financial Strength
-
- 2023-06-03T14:25:01+00:00
Rainbow Children's Medicare Ltd - 543524 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find attached copies of newspaper advertisement published today i.e., June 3, 2023 in Business Standard (English Edition) and Surya (Telugu Edition) intimating that the 25th Annual General Meeting of the Company will be held on Thursday, June 29, 2023 at 11:30 A.M IST through Video Conferencing/ Other Audio Visual Means ("VC/ OAVM").
Read More -
- 2023-05-31T15:04:19+00:00
Rainbow Children's Medicare Ltd - 543524 - Disclosure Under Regulation 30(5) Of SEBI(LODR) 2015
Pursuant to Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find attached details of Key Managerial Personnel (KMP) of the Company authorised to determine materiality of an event or information.
Read More -
- 2023-05-31T14:34:18+00:00
Rainbow Children's Medicare Ltd - 543524 - Appointment Of Chief Financial Officer Of The Company
With reference to the captioned subject, please take note that upon recommendation of the Nomination and Remuneration Committee and the Audit Committee, the Board of Directors in their meeting held today i.e., May 31, 2023, approved appointment of Mr. Vikas Maheshwari as the Chief Financial Officer (Key Managerial Personnel) of the Company with effect from June 1, 2023.
Read More -
- 2023-05-31T14:28:15+00:00
Rainbow Children's Medicare Ltd - 543524 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
With reference to the captioned subject, please take note that Mr. R Gowrisankar, has resigned from the post of Chief Financial Officer (Key Managerial Personnel) of the Company due to personal reasons effective from May 31, 2023 (close of business hours). Mr. Gowrisankar shall now be serving his notice period and his last working day in the Company will be June 30, 2023.
Read More -
- 2023-05-24T14:59:58+00:00
Rainbow Children's Medicare Ltd - 543524 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Please find enclosed herewith the Annual Secretarial Compliance Report issued by M/s. Ravi & Subramanyam Company Secretaries, for the Financial Year ended March 31, 2023.
Read More -
- 2023-05-22T15:09:59+00:00
Rainbow Children's Medicare Ltd - 543524 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find attached the Transcript of the Investor call held on May 15, 2023, with regard to Financial Results of the Company for Q4 & FY23.
Read More -
- 2023-05-16T09:16:00+00:00
Rainbow Children's Medicare Ltd - 543524 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 and 47 of the Listing Regulations, please find attached copies of newspaper advertisement of Financial Results of the Company for the Quarter and Financial Year ended on March 31, 2023, published in Business Standard and Surya on May 16, 2023.
Read More -
- 2023-05-15T17:12:01+00:00
Rainbow Children's Medicare Ltd - 543524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30 and 46(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that the audio recording of the Company's Conference Call dated May 15, 2023 with the Investors/ Analysts for Q4 & FY23 is available on the Company''s website at: https://www.rainbowhospitals.in/investor-relations/reports/RCML-Q4-and-FY23-Earnings-Audio.mp3
Read More -
- 2023-05-15T10:39:06+00:00
Rainbow Childrens Medicare Results Earnings Call for Q4FY23
Conference Call with Rainbow Childrens Medicare Management and Analysts on Q4FY23 Performance and Outlook. Listen to the full earnings transcript.
Read More -
- 2023-05-15T06:36:41+00:00
Q4FY23 Quarterly & FY23 Annual Result Announced for Rainbow Children's Medicare Ltd.
Healthcare Facilities company Rainbow Children's Medicare announced Q4FY23 & FY23 results: Q4FY23 vs Q4FY22: Revenue: Rs 3,169.66 million vs Rs 2,124.47 million, up 49.20% YoY EBITDA: Rs 980.07 million vs Rs 481.33 million, up 103.62% YoY EBITDA %: 30.92% vs 22.66%, up 826 bps YoY PAT: Rs 538.63 million vs Rs 122.60 million, up 339.34% YoY PAT %: 16.99% vs 5.77%, up 1,122 bps YoY FY23 vs FY22: Revenue: Rs 11,735.74 million vs Rs 9,737.58 million, up 20.52% YoY EBITDA: Rs 3,963.77 million vs Rs 3,048.75 million, up 30.01% YoY EBITDA %: 33.78% vs 31.31%, up 247 bps YoY PAT: Rs 2,123.77 million vs Rs 1,386.73 million, up 53.15% YoY PAT %: 18.10% vs 14.24%, up 386 bps YoY Commenting on the performance for Q4FY23, Dr. Ramesh Kancharla, Chairman & Managing Director, Rainbow Children’s Medicare (RCML), said, “I am pleased to inform you that the company has delivered robust quarterly performance, led by high patient footfall across hospitals. The revenues for Q4FY23 were Rs 3,169.66 million, which is a growth of 49.20% compared to Rs 2,124.47 million in Q4FY22. The EBIDTA for Q4FY23 was Rs 980.07 million, which is a growth of 103.62% compared to Rs 481.33 million in Q4FY22, and the PAT for Q4FY23 was Rs 538.63 million, which is a growth of 339.34% compared to Rs 122.60 million in Q4FY22. The company is focused on executing the business plan, put forth during the IPO, of adding 1000 beds across the target markets. The proposed expansion for the current financial year includes the addition of ~270 beds in Central Hyderabad (60 beds), Hydernagar (50 beds), Anna Nagar (80 beds), and Sarjapur (80 beds). Additional ~160 beds are slated for commencement in the next financial year at Rajahmundry (100 beds) and a new spoke hospital in Bengaluru (60 beds). Furthermore, the company aims to increase its bed count by ~400 across the National Capital Region by FY26-27. The company remains committed to fulfilling its mission of delivering excellent multi-disciplinary pediatric and perinatal care and strives to enhance its service offerings by making constant improvements.” Result PDF
Read More -
- 2023-05-14T16:16:41+00:00
Rainbow Children's Medicare Ltd - 543524 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Regulation 41 of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, we are enclosing herewith the Monitoring Agency Report dated May 8, 2023, issued by HDFC Bank Limited, Monitoring Agency, for the quarter ended March 31, 2023 in respect of utilization of proceeds of the Initial Public Offer of the Company.
Read More -
- 2023-05-14T16:13:49+00:00
Rainbow Children's Medicare Ltd - 543524 - Appointment Of Auditors Of The Company
Please take note that the Board of Directors of the Company in their meeting held today i.e. May 14, 2023, inter-alia, considered and approved the following: 1. Appointment of M/s. S. R. Batliboi & Associates LLP, Chartered Accountants (ICAI Firm Registration No. 101049W/ E300004) as the Statutory Auditors of the Company. 2. Appointment of M/s. Deloitte Touche Tohmatsu India LLP as the Internal Auditors of the Company, for a period of two years i.e., For Financial Year 2023-24 & 2024-25. 3. Re-Appointment of M/s. Ravi & Subramanyam Company Secretaries as the Secretarial Auditors of the Company for the Financial Year 2023 - 24. 4. Re-Appointment of M/s. Lavanya & Associates acted as the Cost Auditors of the Company for the Financial Year 2023-24.
Read More -
- 2023-05-14T16:09:55+00:00
Rainbow Children's Medicare Ltd - 543524 - Appointment Of Auditors Of The Company
Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Regulation 41 of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, we are enclosing herewith the Monitoring Agency Report dated May 8, 2023, issued by HDFC Bank Limited, Monitoring Agency, for the quarter ended March 31, 2023 in respect of utilization of proceeds of the Initial Public Offer of the Company.
Read More -
- 2023-05-14T16:05:43+00:00
Rainbow Children's Medicare Ltd - 543524 - Appointment Of Auditors Of The Company
Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Regulation 41 of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, we are enclosing herewith the Monitoring Agency Report dated May 8, 2023, issued by HDFC Bank Limited, Monitoring Agency, for the quarter ended March 31, 2023 in respect of utilization of proceeds of the Initial Public Offer of the Company.
Read More -
- 2023-05-14T15:59:54+00:00
Rainbow Children's Medicare Ltd - 543524 - Disclosure Of Related Party Transactions For The Half Year Ended March 31, 2023
Please find the enclosed herewith Related Party Transactions of the Company for the half year ended March 31, 2023.
Read More -
- 2023-05-14T15:15:51+00:00
Rainbow Children's Medicare Ltd - 543524 - Announcement under Regulation 30 (LODR)-Dividend Updates
The Board of Directors at their meeting held today May 14, 2023 have recommended payment of final dividend of ? 3/- per Equity Share (@ 30% on a face value of ? 10/- per share) for the Financial Year ended March 31, 2023. The dividend, if approved by the shareholders at the ensuing 25th Annual General Meeting ('AGM') will be dispatched/ credited within 30 days of the AGM.
Read More -
- 2023-05-14T15:09:56+00:00
Rainbow Children's Medicare Ltd - 543524 - Annual General Meeting To Be Held On Thursday, June 29, 2023
The Board of Directors at their meeting held today i.e., May 14, 2023, have, inter alia, approved convening of 25th AGM of the Company on Thursday, 29th June, 2023 through video conference or other audio-visual means.
Read More -
- 2023-05-14T15:02:49+00:00
Rainbow Children's Medicare Ltd - 543524 - Record Date For The Purpose Of Payment Of Final Dividend For Financial Year 2022-23
Pursuant to Regulation 42 of Listing Regulations, the Board has fixed June 22, 2023 as the Record Date for the purpose of payment of Final Dividend for Financial Year 2022-23 (if approved by the Shareholders at the ensuing AGM).
Read More -
- 2023-05-14T14:57:28+00:00
Rainbow Children's Medicare Ltd - 543524 - Re-Appointment Of Dr. Anil Dhawan (DIN: 08191702) As An Independent Director Of The Company
Re-appointment of Dr. Anil Dhawan (DIN: 08191702) as an Independent Director for another term of 5 consecutive years, commencing from August 30, 2023, subject to approval of the shareholders in the ensuing 25th Annual General Meeting. Dr. Dhawan has confirmed that he is not debarred from holding the office of director by virtue of any Order of SEBI or any other authority. The requisite disclosures as per Regulation 30 of Listing Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015, is enclosed as 'Annexure - A'.
Read More -
- 2023-05-14T14:50:34+00:00
Rainbow Children's Medicare Ltd - 543524 - Statement On Deviation Or Variation In Utilisation Of Funds Raised Though Initial Public Offer For The Quarter Ended March 31, 2023
Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended read with SEBI Circular No. CIR/ CFD/CMDl/162/2019 dated December 24, 2019, we hereby confirm that during the quarter ended March 31, 2023, there was no deviation or variation in the utilisation of proceeds of the IPO from the objects stated in the Prospectus dated May 2, 2022. A statement of deviation or variation for the quarter ended March 31, 2023, duly reviewed by the Audit Committee of the Company, is enclosed herewith.
Read More
| Ex-date | Dividend Amount | Dividend Type | Record Date |
|---|
Bonus History
Adani Ports & Special Economic Zone Ltd. has not announced any bonus since Jan 1, 2000.
Check out stocks with top dividendAdani Ports & Special Economic Zone Ltd. has split the face value 1 time since Sept. 23, 2010. Adani Ports & Special Economic Zone Ltd. had last split the face value of its shares from Rs 10 to Rs 2 in 2016.The share has been quoting on an ex-split basis from Sept. 23, 2010.
| Ex-date | Old FV | New FV | Record Date |
|---|---|---|---|
| Sept. 23, 2010 | 10 | FINAL | Sept. 24, 2010 |